Navigation
Life Science Cluster für Hamburg und Schleswig-Holstein

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
Group photo of all clusters at KLIMAready kick-off workshop
Group photo of all clusters at KLIMAready kick-off workshop

Hamburg clusters cooperate in unique KLIMAready project

1.5-degree target, climate neutrality and sustainable processes at all levels. What the world, and therefore also the Free and Hanseatic City of Hamburg, has set ...

Read more …

Minister Madsen visits European XFEL

Schleswig-Holstein's Minister of Economic Affairs, Transport, Employment, Technology and Tourism Claus Ruhe Madsen visited European XFEL yesterday. Mr Madsen familiarized himself with the fields of ...

Read more …
The surgical team prepares for an upcoming operation.
The 5-person SurgMark team has already developed several surgical and wound healing products and achieved approvals as Class III medical devices in the U.S. and Europe – and is now on the verge of FDA approval with SchurSign®. (Image: © stock.adobe.com/Syda Productions)

Medtech start-up SurgMark aims to enter the US market

 In breast imaging, doctors mark suspicious areas with marker clips. With SchurSign®, the Hamburg-based medical technology start-up SurgMark has developed an innovative tissue marker made ...

Read more …
FUSE-AI starts global sales at the G20 Digital Innovation Network in Indonesia. (Image: © FUSE_AI)

FUSE-AI takes off

The G20 Digital Innovation Network is a high-level forum for sharing knowledge, fostering discussion and building partnerships between global innovation players. It aims to serve ...

Read more …
Job board